Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12624001006538
Ethics application status
Approved
Date submitted
8/07/2024
Date registered
20/08/2024
Date last updated
20/08/2024
Date data sharing statement initially provided
20/08/2024
Type of registration
Prospectively registered
Titles & IDs
Public title
Next generation gait analysis in the cloud for patients with Parkinson’s Disease – A feasibility study
Query!
Scientific title
Next generation gait analysis in the cloud for patients with NUSHU for patients with Parkinson’s Disease – A feasibility study
Query!
Secondary ID [1]
312355
0
Nil Known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Parkinson's Disease
334134
0
Query!
Condition category
Condition code
Neurological
330807
330807
0
0
Query!
Parkinson's disease
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Magnes Nushu is a smart shoe with embedded sensors and vibrotactile actuators, capable of real-time gait analysis and gait-driven haptic cueing.
Magnes Nushu enables patients to collect data on their gait and share this data with healthcare professionals (HCPs). Data will be automatically uploaded via a mobile phone app linked to the smart shoes. Data will be available to the Research team in Princess Alexandra Hospital and Queensland University of Technology and the Magnes company who owns the shoe. This non- identifiable data is accessible only if participant gives permission to access the data. Magnes Nushu has the potential to help patients with gait deficits by providing them notifications via vibrations on how they walk to assist normal walking. The vibration function will not be used in this study.
The study is designed in three phases to align with our research objectives directly. The total study duration is 14 weeks, and it is separated into three phases. Duration of each study visits is 1-2 hours. Study participants will be provided with a diary by the study coordinator and asked to maintain the diary to record falls, NUSHU usage and physical activity at each study phase. Participants will be asked to provide this diary back to the study team at their next study visit.
A study member will check in with participants weekly throughout the study to ensure participants are not having issues with using the investigational product and to enquire about any falls or other adverse events that may have occurred.
Phase 1 (week 1-4): Observational phase: Patients will wear the NUSHUs at home while performing their everyday activities (min 1 hr/day).
Phase 2 (week 5-10): Intervention phase: Patients will wear the NUSHU while conducting a Physiotherapy-prescribed daily home-exercise program targeting gait, balance and freezing of gait and while at home performing everyday activities (min 1 hr/day).
Participants will undergo assessment by a Physiotherapist and will receive a tailored home-based exercise program for the subsequent six weeks (i.e., phase 2). The program, utilising evidence-based physical therapy practice will be developed by a Physiotherapist with experience in managing Parkinson's Disease across the disease progression. Exercise prescription will be tailored targeting falls prevention, freezing of gait and endurance. Participants will be supported and monitored through their home-based exercise program while wearing the NUSHUs
Participants will be expected to complete NUSHU inbuilt assessments such as Timed Up and Go tests,10m walk test and tests of standing balance. We expect the exercises will take about 20 minutes per day.
Completing of the exercises is being monitored through the NUSHUs and the NUHSU app. Participants will also be followed weekly via phone call during this period.
Phase 3 (week 11-14): ‘Washout’ and monitoring phase: Patients will continue to wear the NUSHUs at home while performing their everyday activities (min 1 hr/day).
If these participants have a caregiver, they will be invited to participate in the study. participant’s and caregiver’s acceptability of using this new technology of smart shoes as measured by their ratings at the exit survey.
Query!
Intervention code [1]
328850
0
Treatment: Devices
Query!
Intervention code [2]
329060
0
Lifestyle
Query!
Comparator / control treatment
In this study the participants themselves act as a comparator. In phase 1 the observational stage the participants will wear the NUSHUs at home while performing their everyday activities (min 1 hr/day) baseline prior to participants wearing the smart shoes.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
338569
0
The primary outcome measure is participant’s acceptability of using this new technology of smart shoes as measured by their ratings at the exit survey.
Query!
Assessment method [1]
338569
0
The participant’s acceptability of the NUSHU will be assessed by their ratings of the Exit survey which has been designed for the study.
Query!
Timepoint [1]
338569
0
Completion of the study (End of week 14 from intervention commencement)
Query!
Primary outcome [2]
338941
0
The primary outcome measure is caregiver’s acceptability of using this new technology of smart shoes as measured by their ratings at the exit survey.
Query!
Assessment method [2]
338941
0
The caregiver’s acceptability of the NUSHU will be assessed by their ratings of the Exit survey which has been designed for the study.
Query!
Timepoint [2]
338941
0
Completion of the study (End of week 14 from intervention commencement)
Query!
Secondary outcome [1]
436479
0
1. Correlation of gait data acquired from NUSHUs during trial period with the formal assessment- MDS UPDRS done at baseline and at 10-week assessment.
Query!
Assessment method [1]
436479
0
MDS-UPDRS
Query!
Timepoint [1]
436479
0
Baseline (Pre-intervention) and at 10-week assessment(post-intervention commencement)
Query!
Secondary outcome [2]
436480
0
2. Comparison of formal gait/balance assessment at baseline and after having undergone Physiotherapy home-exercise program at 10-week assessment
Query!
Assessment method [2]
436480
0
Participant tailored Physiotherapy home-exercise program eg: 10 Metre Walk test and 6 minute walk test.
Query!
Timepoint [2]
436480
0
Baseline and 10-week assessment(post-intervention commencement)
Query!
Secondary outcome [3]
436481
0
3. Comparison of quality-of-life assessments and falls questionnaires at baseline and after having undergone home-exercise program at 10-week assessment
Query!
Assessment method [3]
436481
0
The following will be assessed as a composite outcome
1.PDQ-39
2.Schwab and England activities of daily living
3 EQ-5D-5L
Query!
Timepoint [3]
436481
0
Baseline and 10-week assessment(post-intervention commencement)
Query!
Secondary outcome [4]
437988
0
4. Correlation of Balance data acquired from NUSHUs during trial period with the formal assessment- Modified Falls and Efficacy Scale done at baseline and at 10-week assessment.(post-intervention commencement)
Query!
Assessment method [4]
437988
0
Modified Falls and Efficacy Scale
Query!
Timepoint [4]
437988
0
Baseline (Pre-intervention) and at 10-week assessment(post-intervention commencement)
Query!
Secondary outcome [5]
438522
0
5.Correlation of gait data acquired from NUSHUs during trial period with the formal assessment Freezing of Gait Questionnaire done at baseline and at 10-week assessment.
Query!
Assessment method [5]
438522
0
Freezing of Gait Questionnaire
Query!
Timepoint [5]
438522
0
Baseline (Pre-intervention) and at 10-week assessment (post-intervention commencement)
Query!
Secondary outcome [6]
438523
0
6.Correlation of gait data acquired from NUSHUs during trial period with the formal assessment- Six-minute Walk test done at baseline and at 10-week assessment.
Query!
Assessment method [6]
438523
0
Six-minute Walk test
Query!
Timepoint [6]
438523
0
Baseline (Pre-intervention) and at 10-week assessment (post-intervention commencement)
Query!
Secondary outcome [7]
438524
0
7. Correlation of gait data acquired from NUSHUs during trial period with the formal assessment-Ten Metre Walk test done at baseline and at 10-week assessment.
Query!
Assessment method [7]
438524
0
Ten Metre Walk test
Query!
Timepoint [7]
438524
0
Baseline (Pre-intervention) and at 10-week assessment (post-intervention commencement)
Query!
Secondary outcome [8]
438527
0
8.Correlation of Balance data acquired from NUSHUs during trial period with the formal assessments. Activities- Specific Balance done at baseline and at 10-week assessment (post-intervention) commencement)
Query!
Assessment method [8]
438527
0
Activities- Specific Balance
Query!
Timepoint [8]
438527
0
Baseline (Pre-intervention) and at 10-week assessment (post-intervention commencement)
Query!
Secondary outcome [9]
438528
0
9.Correlation of Balance data acquired from NUSHUs during trial period with the formal assessment Hoehn and Yahr scale done at baseline and at 10-week assessment (post-intervention) commencement)
Query!
Assessment method [9]
438528
0
Hoehn and Yahr scale
Query!
Timepoint [9]
438528
0
Baseline (Pre-intervention) and at 10-week assessment (post-intervention commencement)
Query!
Secondary outcome [10]
438529
0
10.Correlation of Balance data acquired from NUSHUs during trial period with the formal assessments MDS-UPDRS done at baseline and at 10-week assessment (post-intervention) commencement)
Query!
Assessment method [10]
438529
0
MDS-UPDRS
Query!
Timepoint [10]
438529
0
Baseline (Pre-intervention) and at 10-week assessment (Post-intervention commencement)
Query!
Eligibility
Key inclusion criteria
1. Adults aged 18 years and over
2. Have received diagnosis of Parkinson’s Disease.
3. Able to read and write English.
4. Have access to an Apple iOS device with internet access
5. The participants will be required to wear the NUSHUs during home assessments. Participants will also be provided with a diary to record daily activity.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
None
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
2/09/2024
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
19/02/2025
Query!
Actual
Query!
Date of last data collection
Anticipated
30/04/2025
Query!
Actual
Query!
Sample size
Target
20
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Recruitment hospital [1]
26699
0
Princess Alexandra Hospital - Woolloongabba
Query!
Recruitment postcode(s) [1]
42737
0
4102 - Woolloongabba
Query!
Funding & Sponsors
Funding source category [1]
316763
0
Government body
Query!
Name [1]
316763
0
SERTA Grant- Metro South Health
Query!
Address [1]
316763
0
Query!
Country [1]
316763
0
Australia
Query!
Funding source category [2]
316765
0
University
Query!
Name [2]
316765
0
SERTA Grant- Queensland University of Technology
Query!
Address [2]
316765
0
Query!
Country [2]
316765
0
Australia
Query!
Primary sponsor type
University
Query!
Name
Queensland University of Technology
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
318975
0
None
Query!
Name [1]
318975
0
Query!
Address [1]
318975
0
Query!
Country [1]
318975
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
315531
0
Metro South Human Research Ethics Committee
Query!
Ethics committee address [1]
315531
0
https://metrosouth.health.qld.gov.au/research/about-us/hrec
Query!
Ethics committee country [1]
315531
0
Australia
Query!
Date submitted for ethics approval [1]
315531
0
02/06/2023
Query!
Approval date [1]
315531
0
06/06/2023
Query!
Ethics approval number [1]
315531
0
Query!
Summary
Brief summary
We want to test smart shoes. We want to see if wearing these shoes decreases falls for people with Parkinson’s disease. We can monitor your walking at home when you wear these shoes. In this project we want to test a new way of obtaining objective measures of walking and falls risk in people with Parkinson’s Disease using novel technologies allowing continuous monitoring at home. For this pilot study we want to test the usefulness of such an approach using newly developed smart shoes (‘NUSHUs’, developed by our industry partner Magnes AG) with built-in sensors that study participants can use for walking or exercising at home. These shoes are not approved by the TGA in Australia. The shoes continuously record your mobility. The smart shoes collect data while you are walking or exercising and processes the data using advanced methods. During the study you will receive a training program tailored specifically to your individual needs to complete while wearing the smart shoes. The collected data can be accessed by the treating team so they can track your progress and guide you further via telehealth or in person reviews. By understanding how such a technique can be incorporated into clinical practice, this research will contribute to exploring modern management approaches for patients suffering from Parkinson’s Disease.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
134986
0
Dr Alexander Lehn
Query!
Address
134986
0
Princess Alexandra Hospital,199 Ipswich Road, Woolloongabba, QLD 4102
Query!
Country
134986
0
Australia
Query!
Phone
134986
0
+61 0731764246
Query!
Fax
134986
0
Query!
Email
134986
0
[email protected]
Query!
Contact person for public queries
Name
134987
0
Schible Treasa Kurian
Query!
Address
134987
0
Princess Alexandra Hospital,199 Ipswich Road, Woolloongabba, QLD 4102
Query!
Country
134987
0
Australia
Query!
Phone
134987
0
+61 0436447386
Query!
Fax
134987
0
Query!
Email
134987
0
[email protected]
Query!
Contact person for scientific queries
Name
134988
0
Professor Graham Kerr
Query!
Address
134988
0
Queensland University of Technology | Kelvin Grove, Brisbane, QLD 4059,
Query!
Country
134988
0
Australia
Query!
Phone
134988
0
+61 0731386303
Query!
Fax
134988
0
Query!
Email
134988
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF